Materials Healthcare Sector

PolyNovo

Market Cap: AU$1.0b

Designs, manufactures, and sells biodegradable medical devices in the United States, Australia, New Zealand, and internationally.

Mesa Laboratories

Market Cap: US$659.4m

Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.

ArriVent BioPharma

Market Cap: US$658.2m

A clinical-stage biopharmaceutical company, engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers.

Savara

Market Cap: US$655.2m

A clinical stage biopharmaceutical company, focuses on rare respiratory diseases.

Evolus

Market Cap: US$644.8m

A performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.

CeriBell

Market Cap: US$635.8m

Operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States.

Trevi Therapeutics

Market Cap: US$629.8m

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapy Haduvio for the treatment of chronic cough in idiopathic pulmonary fibrosis (IPF) and refractory chronic cough conditions targeting the central and peripheral nervous systems.

Vir Biotechnology

Market Cap: US$629.0m

A clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally.

Day One Biopharmaceuticals

Market Cap: US$624.4m

A commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States.

Simulations Plus

Market Cap: US$618.4m

Develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide.

Fulgent Genetics

Market Cap: US$610.1m

Provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally.

Dianthus Therapeutics

Market Cap: US$603.0m

A clinical-stage biotechnology company, develops complement therapeutics for patients with severe autoimmune and inflammatory diseases.

AbCellera Biologics

Market Cap: US$601.9m

Engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.

AnaptysBio

Market Cap: US$599.4m

A clinical-stage biotechnology company, focuses in delivering immunology therapeutics.

Arbutus Biopharma

Market Cap: US$597.6m

A clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States.

Beta Bionics

Market Cap: US$597.0m

A commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes.

Integral Diagnostics

Market Cap: AU$926.8m

A healthcare services company, engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand.

Sionna Therapeutics

Market Cap: US$592.6m

A clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF).

Tian'an Technology Group

Market Cap: US$591.7m

Through its subsidiaries, engages in the research, development, and production of graphene products for the health therapy industry in China.

Avanos Medical

Market Cap: US$589.6m

A medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.

Iovance Biotherapeutics

Market Cap: US$587.7m

A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States.

Xencor

Market Cap: US$583.6m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibodies for the treatment of asthma and allergic diseases, autoimmune diseases, and cancer.

KalVista Pharmaceuticals

Market Cap: US$579.7m

A clinical stage pharmaceutical company, engages in the discovery, development, and commercialization of drug therapies inhibitors for diseases with unmet needs.

Community Health Systems

Market Cap: US$573.8m

Owns, leases, and operates general acute care hospitals in the United States.

Immatics

Market Cap: US$570.1m

A clinical-stage biopharmaceutical company, focuses on the research and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States.

InnovAge Holding

Market Cap: US$570.0m

Manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities.

Keros Therapeutics

Market Cap: US$569.8m

A clinical-stage biopharmaceutical company, develops and commercializes novel therapeutics for patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta family of proteins in the United States.

Butterfly Network

Market Cap: US$568.8m

Develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally.

OrthoPediatrics

Market Cap: US$566.5m

A medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally.

Akso Health Group

Market Cap: US$563.9m

Operates a social e-commerce mobile platform in the People’s Republic of China.

Bicycle Therapeutics

Market Cap: US$562.3m

A clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom.

NeuroPace

Market Cap: US$560.2m

Operates as a medical device company in the United States.

Delcath Systems

Market Cap: US$559.0m

An interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe.

Replimune Group

Market Cap: US$556.8m

A clinical-stage biotechnology company, focuses on the development of oncolytic immunotherapies to treat cancer.

Advanced Medical Solutions Group

Market Cap: UK£418.1m

Develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally.

Taysha Gene Therapies

Market Cap: US$549.5m

A clinical-stage biotechnology company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system.